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vaginal mucosa the D0.1cc was considered. Statistical 
significance of the results was proven by a Wilcoxon test for 
paired samples (significant p-value <0.05) 
 
Results: 
 
 
Table 1 shows the obtained values for D90, V90, COIN, DHI 
and %CC for the investigated OM. No significant differences 
resulted among the OM in terms of target coverage (D90 and 
V90) and bladder and rectum sparing (D2cc).  
 
The figure shows average DVHs of the PTV over all 12 cases. 
DVHs obtained with homogIPSA and HIPO show a steeper 
gradient, resulting in smaller volumes exposed to high doses. 
homogIPSA and HIPO result in significantly better values of 
COIN, DHI e %CC values. Furthermore, homogIPSA shows the 
lowest value for the D0.1cc to the mucosa. No differences 
were evidenced between the use of MVC applicators with 
diameters of 25mm and 30mm. 
 
Conclusion: HIPO and homogIPSA should be preferred due to 
their ability to get improved dose homogeneity to the target 
and reduced hot spots to the vaginal mucosa. This is achieved 
by a more effective distribution of source dwelling times 
between central and peripheral catheters. It has to be noted 
that all investigated OM require experience of the planner 
and are not completely user independent. 
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Purpose or Objective: To investigate the dosimetric 
characteristics of GMS BT-125-1 I-125 radioactive seed, 
including dose rate constant, radial dose functions and 
anisotropy functions. 
 
Material and Methods: Dosimetric parameters of GMS BT-
125-1 I-125 seed, including dose rate constant, radial dose 
functions and anisotropy functions were calculated using the 
Monte Carlo code of MCNP5, and measured using 
thermoluminescent dosimeters (TLDs). Monte Carlo 
calculations were also performed for the PharmaSeed BT-125-
1 I-125 seed, PharmaSeed BT-125-2 I-125 seed and model 
6711 I-125 seed. The dosimetric parameters of GMS BT-125-1 
I-125 seed were compared with those of PharmaSeed BT-125-
1 I-125 seed, PharmaSeed BT-125-2 I-125 seed and model 
6711 I-125 seed. The measured results were compared with 
those of Monte Carlo simulation for GMS BT-125-1 I-125 seed. 
 
Results: The MCNP5 calculated dose rate constant of GMS BT-
125-1 I-125 seed was 1.011 . The experimental measured 
dose rate constant of GMS BT-125-1 I-125 seed was 0.967 . 
For radial dose function, the difference between GMS BT-
125-1 I-125 seed and PharmaSeed BT-125-2 I-125 seed were 
typically less than 2.0% with a maximum of 3.3 %. The largest 
differences were 8.1% and 6.2% compared with PharmaSeed 
BT-125-1 and model 6711 I-125 seed, respectively. For 
anisotropy functions, the difference between GMS BT-125-1 I-
125 seed and PharmaSeed BT-125-2 I-125 seed was typically 
<10% with a maximum of about 9.6% when the polar angle 
was larger than 10 degree, and 22.9% when the polar angle 
was smaller than 10 degree. Compared with Monte Carlo 
simulation, the largest differences of radial dose functions 
and anisotropy functions were 14.5% and 29.1%, respectively.  
 
Conclusion: The measured dose rate constant, radial dose 
functions and anisotropy functions for GMS BT-125-1 I-125 
seed showed good agreement with Monte Carlo calculated 
values. The dosimetric parameters of GMS BT-125-1 I-125 
seed are similar to those of PharmaSeed BT-125-2 I-125 seed.  
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Purpose or Objective: The aim of this study was: (i) to 
design a new high-dose-rate (HDR) brachytherapy applicator 
for treating surface lesions larger than 3 cm in diameter and 
up to 5 cm size, using the microSelectron-HDR afterloader 
(Elekta Brachytherapy); (ii) to calculate by means of the 
Monte Carlo (MC) method the dose distribution around the 
new applicator when it is placed over a water phantom; and 
(iii) to validate experimentally the water dose distributions. 
 
Material and Methods: The new applicator is made of 
tungsten, and consists on a set of interchangeable collimators 
without flattening filter. It makes use of three catheters to 
allocate the source at prefixed dwell positions and times to 
produce a homogeneous dose distribution at 3 mm depth in 
the water phantom. The Penelope2008 MC code was used to 
optimize dwell positions and dwell times. Next, the dose 
distribution in a water phantom and leakage dose distribution 
were calculated. Finally, MC data were validated 
experimentally by measuring: dose distributions with 
radiochromic EBT3 films (ISP) for an 192Ir mHDR-v2 source; 
percentage depth-dose (PDD) curve with the parallel-plate 
ionization chamber Advanced Markus (PTW); and absolute 
dose rate with EBT3 films and the PinPoint T31016 (PTW) 
ionization chamber. 
 
Results: PDD and off-axis profiles were obtained normalized 
at a depth of 3 mm along the central applicator axis in a 
cylindrical water phantom. These data can be used for 
treatment planning. Leakage was also scored. The dose 
distributions, PDD, and absolute dose rate calculated agree 
within experimental uncertainties with the doses measured. 
 
Conclusion: The new applicator and the dosimetric data 
provided here will be a valuable tool in clinical practice, 
making treatment of large skin lesions simpler, faster, safer, 
and with minimized dose to surrounding healthy tissues when 
